What is Ketamine Therapy? How it Works and Who it Helps

What Is Ketamine Therapy and How Does It Work?

Ketamine therapy is a medically supervised treatment using sub-anesthetic doses of ketamine — a dissociative anesthetic — to treat psychiatric conditions including depression, anxiety, and PTSD. Ketamine has a long and well-documented pharmacological history, having been FDA-approved as an anesthetic since 1970.

Ketamine has been included on the World Health Organization's List of Essential Medicines since 1985 for its established role as an anesthetic.⁹

Today, providers widely use ketamine at sub-anesthetic doses for mental health care, prescribing it outside its original FDA-approved indication. Off-label prescribing is a standard, legally accepted medical practice across all fields of medicine;¹⁰ approximately 21% of all prescriptions in the United States are written for non-approved indications.¹ A separate section below covers the distinction between racemic ketamine, which is prescribed off-label, and esketamine (Spravato), which is FDA-approved for treatment-resistant depression. Decades of peer-reviewed research across multiple conditions support the evidence base for ketamine's psychiatric applications.

Understanding what ketamine therapy is helps clarify that it is delivered in both in-office and at-home settings under defined care frameworks. It is a medically grounded approach backed by decades of safety data, not an experimental or fringe option.

What Can Ketamine Therapy Help Treat?

Physicians and psychiatric providers utilize ketamine therapy to address several psychiatric conditions, most commonly depression, anxiety disorders, and PTSD. While esketamine (Spravato) holds FDA approval specifically for treatment-resistant depression and major depressive disorder with suicidal ideation, racemic ketamine is prescribed outside its FDA-approved indication for a broader range of mental health challenges.

Peer-reviewed evidence supports ketamine's application across the following areas:

• Depression: The most extensively studied psychiatric application for ketamine is depression, including treatment-resistant depression. Because the medication acts through a different mechanism than traditional antidepressants, many people report noticeable symptom relief within hours or days of their first session. More durable benefits typically develop over a series of treatments.
• Anxiety disorders: Peer-reviewed research, including Mindbloom's published outcomes data, supports ketamine's use for generalized anxiety and related conditions. Published data demonstrates meaningful reductions in acute anxiety symptoms and the cognitive patterns that sustain them.⁷
• PTSD: Research supports ketamine's role in reducing core PTSD symptoms. Ketamine helps alleviate hypervigilance, intrusive thoughts, and emotional numbing by allowing patients to process trauma in a more flexible neural state.⁸
• Other areas: Research is actively expanding into OCD, chronic pain, bipolar depression, and behavioral health contexts such as grief, burnout, and habit change. While evidence strength varies by indication, the research literature continues to broaden.

Patients need not exhaust all other options before considering ketamine therapy. Ketamine serves as an evidence-based option for adults experiencing multiple psychiatric conditions, and eligibility is determined through a thorough medical evaluation rather than simply whether prior medications have failed.

How Does Ketamine Therapy Work?

Ketamine works differently from traditional psychiatric medications like SSRIs. Rather than targeting serotonin or norepinephrine, the medication modulates glutamate signaling — the brain's most abundant excitatory neurotransmitter — by temporarily adjusting activity at NMDA receptors.²

Modulating these receptors triggers a biological cascade that increases neuroplasticity, which is the brain's ability to form and strengthen new synaptic connections. Increased neuroplasticity explains why ketamine can produce rapid shifts in mood and cognition; the medication creates a temporary window in which entrenched thought patterns and rigid neural pathways become more flexible. Traditional antidepressants may take weeks to produce effects because they rely on slower receptor adaptation, whereas ketamine's glutamate-driven mechanism can produce measurable changes within hours.²

Ketamine is most effective when utilized as one component of a broader therapeutic process, where preparation, medical oversight, and integration practices help translate these neuroplastic changes into lasting behavioral shifts.

Ketamine's rapid action on glutamate and neuroplasticity enables both the speed of initial relief and the potential for durable change when combined with care support.

What to Expect During Ketamine Therapy

The general arc of ketamine therapy involves screening and preparation, the active dosing session, the post-session period, and the overall therapeutic course. While specific details vary by provider and setting (such as in-office versus at-home care), protocol-driven programs share several foundational elements.

What Happens Before a Ketamine Therapy Session?

The pre-session process involves comprehensive health and psychiatric screening, a medication review, informed consent, and detailed preparation instructions. During screening, a licensed provider evaluates your cardiovascular health, psychiatric history, substance use history, and current medications to ensure the approach is medically appropriate.

Preparation often includes guidance on mindset, optimizing your physical environment, and practical logistics, such as arranging for a support person to be present and avoiding food or drink as directed. Safety begins during the screening phase, establishing a secure foundation long before any medication is administered.

What Happens During a Ketamine Therapy Session?

During the active session, ketamine is administered at a provider-determined therapeutic dose while you are monitored through vital sign checks and care check-ins. Sessions take place under strict provider oversight, whether you are in a physician's office or completing the session at home.

In at-home settings, a peer treatment monitor is required to be present for the duration of the experience, while care staff fulfill the role in-office. While the exact duration of the dosing period varies across settings, supervised administration remains the constant safety standard.

What Happens After a Ketamine Therapy Session?

The post-session period involves a gradual transition back to your baseline state of consciousness. The only universally consistent restriction is that you must avoid driving or operating heavy machinery until after a full night of sleep. During the post-session window, integration functions as a core component of the therapeutic process — not an optional add-on.

Practices like journaling, guided reflection, and coaching sessions help translate the neuroplastic window opened by ketamine into lasting changes in emotional regulation and behavior. Individual experiences vary; some people prefer to keep their schedule clear for the day, while others feel ready to resume non-driving activities later that afternoon. Follow-up consultations help track progress and adjust the care plan.

What Can Ketamine Therapy Feel Like?

Most people describe the subjective experience as a sense of deep relaxation, an altered perception of time, and a feeling of distance from everyday thought patterns. Some individuals also experience visual or sensory changes during the active medication window. Within a supervised setting, dissociation represents a known — and often therapeutic — aspect of the experience, and many people find the shift in perspective to be highly meaningful or insightful.

If the experience feels unfamiliar or intense, preparation materials and the presence of your support person can help you navigate it comfortably. Common physical sensations may include mild dizziness or nausea, which typically resolve during or shortly after the session.

How Many Sessions Can Ketamine Therapy Include?

Providers typically deliver ketamine therapy as a defined series of sessions rather than a single, isolated dose. Mindbloom's programs, for example, include 6, 12, or 18 sessions, personalized based on your medical needs and mental health goals. Many people report noticeable improvement early in the therapeutic course, with more durable and cumulative benefits developing over subsequent sessions.

Session frequency is personalized based on individual needs and physician guidance; sessions may be more frequent at the outset to establish therapeutic momentum, with the cadence adjusted over time based on your progress. Integration practices and ongoing care support help sustain progress.

Ketamine Therapy Side Effects and Safety

When evaluating safety, you should distinguish clearly between side effects — which are expected, non-serious reactions — and adverse events, which are serious, unexpected medical incidents. The most common side effects of ketamine therapy include dissociation, a temporary increase in blood pressure, nausea, dizziness, and fatigue.

Ketamine is a Schedule III controlled substance, and physical dependence is a recognized pharmacological possibility. Dependence is primarily documented in chronic, unsupervised recreational use patterns involving frequent, high-dose exposure over extended periods.¹¹ The sub-anesthetic, provider-determined dosing used in therapeutic settings represents a fundamentally different exposure pattern. Medical screening for substance use history, defined session counts, and ongoing physician oversight are designed to mitigate the dependence risk proactively.

When side effects occur, they are usually limited to the active medication window; clinicians counsel patients on expected timing, monitor symptoms such as blood pressure changes and nausea, and provide follow-up if symptoms persist beyond the session. Common side effects include:

• Temporary blood pressure increase: Some people experience a temporary increase in blood pressure during the session. The reason is pharmacologic: ketamine has sympathomimetic properties, meaning it temporarily stimulates the cardiovascular system.
• Dissociation: The medication temporarily alters sensory perception and spatial awareness, which is a core pharmacological effect of NMDA receptor modulation.
• Nausea and dizziness: The vestibular and gastrointestinal systems can be temporarily affected during the active medication window.

Thorough screening, ongoing supervision, and protocol-driven care — not dose size alone — determine how safely ketamine therapy is delivered.² Understanding the potential effects helps patients engage with the process confidently.

Who Is a Good Candidate for Ketamine Therapy?

A comprehensive medical evaluation — not a simple checklist — determines eligibility. What is ketamine therapy right for? That depends on your unique medical and psychiatric profile.

A licensed provider carefully assesses your medical history, psychiatric background, current medications, and specific treatment goals to determine if the approach is right for you.

Adults experiencing depression, anxiety, PTSD, or related conditions may benefit from the treatment. Candidates include individuals who have not responded adequately to other interventions, though prior medication experience is just one factor a physician considers, not a strict prerequisite.

Conversely, ketamine therapy may not be appropriate for individuals with uncontrolled hypertension, active psychotic disorders, or certain substance use disorders. Your provider will evaluate the cardiovascular and psychiatric factors during the screening process.

Every candidacy decision reflects the individual's unique medical and psychiatric profile. The screening process exists to match the right people with the right therapy in the appropriate care setting.

How Is Ketamine Administered?

Ketamine Infusion and Other Routes of Administration

Ketamine can be administered through several routes, each with distinct pharmacological characteristics. The most common include intravenous (IV) infusion, sublingual tablets, subcutaneous injection, and intramuscular injection. Esketamine (Spravato) is delivered as an intranasal spray.

Providers and patients typically select the route together, weighing therapeutic goals, setting, bioavailability, and individual factors.

IV infusion (ketamine infusion) is typically administered over 40 minutes in a medical setting with direct provider monitoring. Sublingual tablets are the most common home-based protocol, with meaningful published evidence for psychiatric use at sub-anesthetic doses. Subcutaneous administration (Injectables) offers higher bioavailability than sublingual tablets while maintaining the convenience of home-based care.

Intramuscular injection is also utilized in some care settings. All routes represent different therapeutic approaches for different needs, without a strict superiority hierarchy.

How ketamine is administered shapes the session experience, the care setting, and the oversight model. Understanding the options helps readers have informed conversations with their provider about which approach fits their needs.

How Ketamine and Esketamine Differ

Ketamine (often called racemic ketamine) contains two mirror-image molecules: S-ketamine and R-ketamine. Esketamine, sold under the brand name Spravato, is the isolated S-ketamine enantiomer and is FDA-approved as a nasal spray for treatment-resistant depression and major depressive disorder with suicidal ideation.

The two formulations differ across several key dimensions:

• Chemical form: Racemic ketamine contains both S and R enantiomers, while Spravato contains the S-enantiomer only.
• FDA status: Racemic ketamine was approved as an anesthetic in 1970, and its psychiatric use falls outside that original approval. Esketamine was FDA-approved for treatment-resistant depression in 2019.
• Routes of administration: Racemic ketamine is delivered via IV infusion, sublingual, subcutaneous, or intramuscular routes. Esketamine is intranasal only.
• Setting: Racemic ketamine is used in-office or at-home depending on the route and provider. Esketamine is restricted to a REMS-certified healthcare setting only.
• Access: Any licensed physician can prescribe racemic ketamine off-label, whereas esketamine requires a REMS-certified provider. The distinction directly shapes the access models a reader would encounter.

IV infusion is the most studied in-office route, while sublingual ketamine is the most common home-based protocol. Subcutaneous administration offers higher bioavailability than sublingual tablets while maintaining the convenience of home-based care.

The choice between ketamine and esketamine depends on medical needs, access, and individual preference. A specialist can help evaluate which formulation fits your situation.

How Defined Treatment Frameworks Support Safe Ketamine Therapy

Responsible ketamine therapy relies on a robust care architecture designed to support safety, consistency, and appropriate care follow-up. The key elements that differentiate protocol-driven ketamine therapy from unstructured use include comprehensive medical and psychiatric screening before the first session. Licensed providers determine dosing, monitor progress, and adjust care plans as needed.

Preparation before sessions and integration support afterward help translate neuroplastic changes into durable emotional shifts. During at-home sessions, a peer treatment monitor is required to be present, and ongoing support is provided through follow-up consultations.

Mindbloom delivers the care framework at scale. The care model includes provider consults, guide coaching sessions, unlimited Group Integration Circles, unlimited guide messaging, the Bloombox experiential toolkit, and comprehensive app-guided programs with custom soundscapes. A peer treatment monitor is required to be present during every session.

Mindbloom is also the only home-based ketamine provider offering subcutaneous administration (Injectables) in addition to sublingual tablets. Mindbloom's guided ketamine therapy starts at $215 per session for a new client 6-session program, billed as $430/month for 3 months (totaling $1,290). Returning clients receive preferred pricing, paying $159 per session for a 6-session program.

Building on decades of medical research, Mindbloom has published two of the largest peer-reviewed, real-world outcomes studies of home-based ketamine therapy to date.^6,7 In a peer-reviewed study of 11,441 patients, 89% reported improvement in depression and anxiety symptoms.⁷ Furthermore, 56.4% met criteria for depression response, and 56.1% met criteria for anxiety response.⁷ Individual results may vary.

Mindbloom's reported depression response rates (56–63%) exceed response rates reported in selected meta-analyses of talk therapy³ and selected SSRI antidepressant studies,⁴ although direct comparisons across modalities should be interpreted cautiously because study designs, patient populations, and outcome measures differ. Response rates are comparable to or modestly exceed those reported in selected IV ketamine studies.⁵

Questions about what ketamine therapy is and whether it fits your needs can be addressed during a medical evaluation. Get Started to find out if you are eligible for treatment.

Important Safety Information

Ketamine is not FDA-approved for PTSD, depression, or anxiety. Common side effects include dissociation, increased blood pressure, nausea, dizziness, and cognitive impairment. Ketamine has abuse potential and is not appropriate for patients with uncontrolled hypertension, psychotic disorders, or substance use disorders.

Do not drive or operate machinery until the day after treatment. Individual results may vary. Full safety information: www.mindbloom.com/safety-information

Off-Label Use Disclosure

Ketamine is FDA-approved only as an anesthetic. Use for mental health conditions represents off-label prescribing by licensed clinicians based on clinical judgment. Schedule III Controlled Substance - DEA regulations apply.